Ju Dong Yang was named medical director of the Liver Cancer Program at Cedars-Sinai Cancer Center.
Ju Dong Yang is a liver cancer clinician-researcher who studies epidemiology, health disparities and outcomes, and biomarkers. His work focuses on early detection of liver cancer.
As medical director, Yang will continue to address liver cancer and non-alcoholic fatty liver disease in high-risk populations.
Yang intends to establish a multidisciplinary clinic that allows patients to receive care from multiple specialty providers at one location, increase the number of clinical trials of liver cancer treatments, and investigate biomarkers that will help predict treatment outcomes.
Yang will also begin community-based education initiatives that will better facilitate the accrual of clinical trials.
Yang has completed fellowships in gastroenterology, hepatology, and transplant hepatology. He holds a master’s degree in clinical and translational research from the Mayo Clinic.
